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Understanding the mechanisms that help promote protective immune responses to pathogens is a major challenge in
biomedical research and an important goal for the design of innovative therapeutic or vaccination strategies. While
natural killer (NK) cells can directly contribute to the control of viral replication, whether, and how, they may help
orchestrate global antiviral defense is largely unknown. To address this question, we took advantage of the well-
defined molecular interactions involved in the recognition of mouse cytomegalovirus (MCMV) by NK cells. By using
congenic or mutant mice and wild-type versus genetically engineered viruses, we examined the consequences on
antiviral CD8 T cell responses of specific defects in the ability of the NK cells to control MCMV. This system allowed us
to demonstrate, to our knowledge for the first time, that NK cells accelerate CD8 T cell responses against a viral
infection in vivo. Moreover, we identify the underlying mechanism as the ability of NK cells to limit IFN-a/b production
to levels not immunosuppressive to the host. This is achieved through the early control of cytomegalovirus, which
dramatically reduces the activation of plasmacytoid dendritic cells (pDCs) for cytokine production, preserves the
conventional dendritic cell (cDC) compartment, and accelerates antiviral CD8 T cell responses. Conversely, exogenous
IFN-a administration in resistant animals ablates cDCs and delays CD8 T cell activation in the face of NK cell control of
viral replication. Collectively, our data demonstrate that the ability of NK cells to respond very early to
cytomegalovirus infection critically contributes to balance the intensity of other innate immune responses, which
dampens early immunopathology and promotes optimal initiation of antiviral CD8 T cell responses. Thus, the extent to
which NK cell responses benefit the host goes beyond their direct antiviral effects and extends to the prevention of
innate cytokine shock and to the promotion of adaptive immunity.
Citation: Robbins SH, Bessou G, Cornillon A, Zucchini N, Rupp B, et al. (2007) Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog 3(8):
e123. doi:10.1371/journal.ppat.0030123
Introduction
The development of antiviral immune responses involves
the orchestration of a complex network of innate and
adaptive immune cells to promote health over disease.
Natural killer (NK) cells, plasmacytoid dendritic cells (pDCs),
CD11b and CD8a conventional dendritic cells (cDCs), B cells,
and CD8 T cells have all been demonstrated to be important
for the generation of protective immunity to various viral
infections [1–6]. However, how the antiviral defense as a
whole is coordinated, and in particular how the functions of
different types of immune cells impact the shaping of the
global immune response to viruses in vivo, is not thoroughly
understood.
The importance of an efﬁcient NK cell response for the
promotion of a favorable outcome to viral infections has
been demonstrated in both mice and humans [2,7], and the
rapid activation of NK cells after infection is a hallmark of
their potency as innate immune system effectors [2]. Increas-
ing evidence supports the idea that optimal coordination of
immune responses involves an intricate relationship between
NK cells and other innate leukocytes. For example, several
reports have documented the importance of NK/DC ‘‘cross-
talk’’ for the reciprocal activation of these cell types and in
the promotion of antitumor immunity as recently reviewed
[3,8]. Others have shown the involvement of macrophages as
an intermediary in the activation of NK cells via Va14i NK T
cells [9]. NK cells have also been shown to have the capacity to
interact with neighboring NK cells as well as T cells to
stimulate cellular proliferation [10,11].
pDCs were initially identiﬁed in humans and mice based on
the unique ability of these cells to secrete enormous amounts
of IFN-a/b early in response to viral challenge [12]. pDCs
respond in this way as a consequence of their ability to
recognize molecular signatures of viruses in a manner that is
independent of pDC infection [12,13]. Early during the
course of murine cytomegalovirus (MCMV) infection, pDCs
are the major producers of interferons a and b (IFN-a/b)
[13,14], which are critical for host survival [15,16]. IFN-a/b
have direct antiviral effects because they can inhibit viral
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cells defense mechanisms that protect them from viral
infection. IFN-a/b also mediate a variety of immunoregula-
tory functions, either activating or inhibitory [17,18]. They
contribute to the proliferation of NK cells and induce them
to express functional cytotoxic granules, promote cDC
phenotypic and functional maturation, and can help to
activate antiviral CD8 T cells. In contrast, depending on the
context, IFN-a/b can also compromise the immune response
of the host by inhibiting DC differentiation [19] or by directly
leading to the attrition of CD8 T cells [20,21]. Indeed,
different viruses have recently been suggested to induce a
profound immunosuppression in the host by inducing over-
whelming levels of IFN-a/b [19]. The importance of the host
genotypes in the efﬁciency of IFN-a/b antiviral functions in
the context of the infection with speciﬁc viruses are well
documented [22,23]. In contrast, it is not known whether
naturally occurring differences in the interactions between a
virus and its hosts exist that may shape IFN-a/b responses by
speciﬁcally dampening the immunosuppressive functions of
these cytokines that are detrimental to the host and beneﬁcial
to the pathogen. The identiﬁcation of such conditions will
help to better understand the physiopathology of viral
infection and may lead to the development of innovative
treatments to ﬁght these infections.
In the early phase of MCMV infection there is a tight
temporal relationship between the activation and exertion of
effector functions between NK cells and pDCs because the
production of IFN-a/b by pDCs promotes NK cell prolifer-
ation and cytotoxicity [13,24]. However, the impact of NK cell
functions on the pDC response to MCMV remains unex-
plored. The goal of this study was therefore to evaluate the
effect of efﬁcient NK cell responses on pDC IFN-a/b
production and on the development of the adaptive immune
responses of the host.
C57BL/6 mice are able to mount NK cell responses that can
control MCMV replication very efﬁciently, due to their
expression of the Ly49H activating receptor, which endows
NK cells with the ability to recognize and kill viral-infected
cells expressing the viral ligand m157 (reviewed in [1]).
Although the NK cells from BALB/c and other strains of mice
lacking the Ly49H gene are strongly activated for the
acquisition of the cytotoxic machinery and for the produc-
tion of IFN-c early after MCMV infection, they fail to
recognize and kill infected cells and can therefore be
considered inefﬁcient. Inbred mouse strains that are resistant
or sensitive to MCMV infection in an NK cell–dependent
manner differ in many other immune parameters, including
major histocompatibility (MHC) haplotype as well as DC
subset frequency and function [25]. Therefore, rigorous
evaluation of the impact of NK cell responses on pDC and
adaptive responses requires comparison between mice of the
same genetic background differing only in the ability of their
NK cells to control the infection. For this, we took advantage
of the fact that the Ly49H/m157 activation axis is sufﬁcient
for NK cell control of MCMV when introduced into the
BALB/c genome [26]. The response of pDCs and CD8 T cells
to MCMV were therefore compared between BALB/c mice
(Ly49H
 ) and animals on the BALB/c background that are
congenic for the C57BL/6 natural killer complex and in
particular for Ly49H (C.B6-Klra8
Cmv1-r/UwaJ mice, hereafter
named Klra8 [27]). This system thus provides a unique model
to study antiviral immune responses in vivo in the context of
both efﬁcient (Ly49H
þ) and inefﬁcient (Ly49H
 ) NK cell
activation, in the absence of any broad defect in NK cell
development or activity that may affect the homeostasis or
functions of other immune cells. This system allowed us to
demonstrate, to our knowledge for the ﬁrst time, that NK
cells accelerate CD8 T cell responses against a viral infection
in vivo. Moreover, we identiﬁed the underlying mechanism—
the ability of NK cells to limit pDC IFN-a/b production to
levels not immunosuppressive to the host—which itself
results from the early control of viral replication.
Results
Early Control of Cytomegalovirus Replication by NK Cells
Is Accompanied by Decreased pDC Cytokine Production
Ly49H triggering by m157 is required for the proliferation
and accumulation of NK cells between days 3 and 7 after
MCMV infection [28]. Therefore, we ﬁrst used NK cell
expansion as an indicator to show that Klra8 and BALB/c
mice generate an NK cell response of different quality to
MCMV infection (Figure S1A). We next compared the ability
of Klra8 and BALB/c mice to control early viral load.
Consistent with reported differences in viral load seen
between mice lacking or possessing the Ly49H gene
[26,29,30], there was a substantially higher viral burden
within the spleens of BALB/c mice when compared to those
of congenic Klra8 animals (Figure S1B). In addition, NK cell
depletion in Klra8 mice increased viral replication to levels
similar to those observed in BALB/c animals (Figure S1C).
Thus, these data conﬁrm previous reports demonstrating that
Klra8 mice mount a strong NK cell response that is able to
efﬁciently control MCMV replication, in contrast to BALB/c
animals.
To evaluate the impact of efﬁcient antiviral NK cell activity
on the induction of IFN-a/b, we ﬁrst examined the levels of
the cytokines present in the serum of Klra8 and BALB/c mice.
The serum levels of IFN-a/b were dramatically lower (100-
fold) at the peak of the response (day 1.5), and decreased at all
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Author Summary
To fight viral infections, vertebrates have developed a battery of
innate and adaptive immune responses aimed at inhibiting viral
replication or at killing infected cells. These responses include the
early production of innate antiviral cytokines, especially interferons
a and b (IFN-a/b), and the activation of cytotoxic lymphocytes such
as the innate natural killer (NK) cells and the adaptive CD8 T cells.
While critical for antiviral defense, cytokine or CD8 T cell responses
can be detrimental or even fatal to the host when deregulated.
Therefore, we need to better understand how the different arms of
antiviral immunity are regulated. In particular, NK cells are proposed
to play a protective role in a variety of viral infection in humans, but
the underlying mechanisms remain poorly understood. Here, in a
mouse model of cytomegalovirus infection, we demonstrate that NK
cells prevent an excessive production of IFN-a/b and promote more
efficient antiviral CD8 T cell responses. We thus show that NK cells
can help promote health over disease during viral infections by
regulating both innate and adaptive immune responses. It will be
important to examine in humans whether NK cells control innate
cytokine production to prevent immunopathology and to promote
adaptive immunity against herpesviruses, HIV-1, influenza, or SARS.other times points examined, in Klra8 mice as compared to
BALB/c mice (Figure 1A). The serum levels of other innate
cytokines were also signiﬁcantly lower in Klra8 mice,
including IL-12p70 (Figure 1A) and TNF-a (unpublished).
Similar results were observed when comparing serum
cytokine levels between control-treated and NK cell–depleted
Klra8 mice (Figure S2 and unpublished data). Thus, while the
systemic production of IFN-a/b and of other innate cytokines
in response to MCMV infection is very high in susceptible
animals, it is greatly reduced in the presence of an NK cell
response that controls viral replication early and efﬁciently.
In MCMV-infected 129 or C57BL/6 immunocompetent
animals, most of the systemic production of IFN-a/b and a
signiﬁcant proportion of that of IL-12p70 comes from pDCs
[13,14,31], which are not productively infected [13,32], and
does not come from infected cells ([13] and unpublished
data). To our knowledge, the contribution of pDCs to IFN-a/b
or other innate cytokine production has not been assessed in
animals on a BALB/c genetic background, which are the most
susceptible to MCMV infection. cDCs infected with MCMV in
vitro have been reported to produce high levels of IFN-a/b
[33,34], and more generally, any virus-infected cell could
theoretically produce these cytokines. Therefore, the increase
in the systemic levels of IFN-a/b observed in BALB/c animals
could result either from a high activation of pDCs or from a
more signiﬁcant contribution to this function from other cell
types or from the high numbers of infected cells in these
animals [33,34]. Therefore, we next compared the activation
of pDCs for IFN-a/b or IL-12p70 production between BALB/c
and Klra8 animals by intracellular staining for these cytokines
on ex vivo isolated splenocytes (Figure 1B). Less than 1% of
the pDCs were found to produce IFN-a/b or IL-12 in Klra8 as
compared to 10%–12% in BALB/c mice. Consistent with
previous reports on 129 or C57BL/6 animals [14,35], pDCs
were the sole producers of IFN-a/b at all the time points
examined in BALB/c and Klra8 mice (unpublished data). Both
pDCs and cDCs contributed to the production of IL-12 in
Klra8 mice. However, the high IL-12p70 serum levels
observed in BALB/c mice could solely be attributed to pDCs
(Figure 1B and unpublished data). Therefore, a very high
activation of pDCs for innate cytokine production was
observed in BALB/c mice, which was drastically reduced in
congenic animals endowed with efﬁcient antiviral NK cell
functions.
To further link the early viral load and the level of IFN-a/b
production by pDCs, we performed infections of BALB/c and
Klra8 mice with 5-fold serial dilutions of viral inoculums,
leading to challenge doses from 10
3 to 1.25 3 10
5 pfu/mouse.
Systemic IFN-a titers in these animals were measured by
Figure 1. Decreased pDC Cytokine Production in the Presence of Ly49H/
m157-Mediated NK Cell Activation
(A) Serum from Klra8 and BALB/c mice was collected on days 0, 1.5, 2,
and 3 post–MCMV infection. Cytokine levels of IFN-a and IL-12p70 were
determined by ELISA. Results are expressed as mean 6 SD of three mice
per group.
(B) Splenic leukocytes were isolated from Klra8 and BALB/c mice and
analyzed for the frequency of IFN-a/b
þ pDCs and IL-12
þ pDCs directly ex
vivo. Numbers in dot plots represent the percent of IFN-a/b
þand percent
of IL-12
þ cells within the total pDC population. One representative
animal from groups of three mice for day 1.5 post–MCMV infection is
shown. Graphs represent the total numbers of IFN-a/b
þ pDCs and IL-12
þ
pDCs present in the spleens of Klra8 and BALB/c mice on days 0, 1.5, 2,
and 3 post–MCMV infection. Results are expressed as mean 6 SD of
three mice per group and in ten thousands of cells.
One experiment representative of three for (A, B) is shown. *p   0.05; **p
  0.01; § ¼ not detected.
doi:10.1371/journal.ppat.0030123.g001
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producing IFN-a/b by ﬂow cytometry (Figure S2). The results
clearly showed that the amount of IFN-a/b secreted by pDCs
increases dramatically at high viral dose inoculums in Klra8
mice to levels similar to those observed in BALB/c animals. A
5-fold difference in the virus inoculums from 5310
3 to 2.53
10
4 pfu/mouse is sufﬁcient to switch on IFN-a/b production
by pDCs in Klra8 mice from very low levels to nearly maximal
levels similar to those observed in BALB/c animals. At low
dose viral infection (10
3 pfu/mouse), BALB/c mice are still
activated for nearly maximal pDC cytokine production. Thus,
BALB/c and Klra8 animals are conﬁrmed to exhibit dramat-
ically different levels of pDC IFN-a/b production over more
than a 10-fold range of viral inoculums. These data also show
that the pDCs of Klra8 mice are able to produce high levels of
IFN-a/b under conditions of stimulation with high viral
inoculums. Moreover, NK cell depletion in Klra8 mice
infected with low virus inoculums was also shown to lead to
a dramatic increase in pDC IFN-a/b production, almost to the
levels observed in BALB/c animals (Figure S2). Altogether,
these data thus show that the ability of the host to control
MCMV replication early through NK cell responses limits the
activation of pDCs and therefore prevents the induction of
very high systemic levels of IFN-a/b and IL-12. These data also
demonstrate that the pDCs of Klra8 mice are not intrinsically
deﬁcient for IFN-a/b production in response to MCMV
infection.
Early Control of MCMV Replication by NK Cells Prevents
the Ablation of cDC and Accelerates the Development of
Effector Antiviral CD8 T Cell Responses
High systemic levels of IFN-a/b production have been
shown to lead to the ablation of cDCs [19] and to the attrition
of both antigen-speciﬁc and bystander CD8 T cell popula-
tions during infection with lymphocytic choriomeningitis
virus (LCMV) [20,21]. We therefore hypothesized that the
high systemic levels of IFN-a/b induced during MCMV
infection in the context of inefﬁcient NK cell activity could
lead to the ablation of cDCs and may impinge on the
development of antiviral CD8 T cell responses. Indeed, it has
been previously reported that MCMV infection leads to a
severe ablation of CD8a cDCs in BALB/c mice that is
prevented by efﬁcient antiviral NK cell functions in C57BL/
6 animals [36]. However, the cause for this ablation of cDCs in
BALB/c animals has not been identiﬁed, and the effect of this
ablation on the development of antiviral CD8 T cells has not
been evaluated. Thus, we next compared the numbers of DC
subsets and the activation of antiviral CD8 T cells at different
time points after infection between Klra8 and BALB/c mice.
We ﬁrst conﬁrmed that pDC numbers remained at
homeostatic levels in BALB/c mice throughout the early
phase of MCMV infection, while a severe ablation of cDCs
occurred for both the CD11b and CD8a subsets (Figure 2). In
contrast, in the presence of an efﬁcient NK cell response, in
Klra8 mice, both the cDC and pDC compartments were
preserved, consistent with the previous observations reported
in C57BL/6 animals [36].
We next compared the kinetics of CD8 T cell expansion
between Klra8 and BALB/c mice (Figure 3A). We observed a
signiﬁcant increase in total CD8 T cells in the spleen at day 4
post-infection in Klra8 mice but only later in BALB/c animals.
We investigated whether this accelerated expansion of CD8 T
cells was a result of a faster activation of antiviral effector
CD8 T cells. We ﬁrst analyzed total splenic CD8 T cells for the
expression of an O-glycosylated, activation-associated iso-
form of CD43. The 1B11 monoclonal antibody (mAb)
speciﬁcally recognizes this isoform of CD43 on CD8 T
lymphocytes [37] and identiﬁes the subset of effector cells
capable of IFN-c production and potent cytolytic activity ex
vivo during the acute phase of a variety of viral infections [38–
42]. We observed the appearance of CD43
hi effector CD8 T
cells starting at day 4 post-infection in Klra8 mice but only
later in BALB/c animals (Figure 3B). We then used MHC class
I tetramers loaded with a peptide derived from the IE-1
protein of MCMV in order to quantify the subset of antiviral
CD8 T cells speciﬁc to this epitope (Figure 3C). We observed a
faster expansion of the anti-IE-1 CD8 T cells in Klra8 mice,
similar to what was observed for total or effector CD8 T
lymphocytes. Similar results were obtained when analyzing
the CD8 T cell response against another viral peptide, derived
from protein m164 (unpublished data). Conversely, and in
Figure 2. Antiviral NK Cell Responses Prevent Ablation of the cDC during
MCMV Infection
Splenic leukocytes were isolated from Klra8 and BALB/c mice and
analyzed for the frequency of pDCs (120G8
þ CD11c
int), CD11b cDCs
(120G8
 CD11c
hi CD8a
 ), and CD8a cDCs (120G8
 CD11c
hi CD8a
þ) within
the DX5
 and TCRb
 population. Numbers in dot plots represent percent
pDCs, percent CD11b cDCs, and percent CD8a cDCs within the total
splenocyte population for one representative animal from groups of
three mice for days 0 and 2 post–MCMV infection. Graphs represent the
total numbers (in millions) of pDCs, CD11b cDCs, and CD8a cDCs present
in the spleens of Klra8 and BALB/c mice on days 0, 1.5, 2, and 3 post–
MCMV infection. Results are expressed as mean 6 SD of three mice per
group. One experiment representative of three is shown. *p   0.05; **p
  0.01.
doi:10.1371/journal.ppat.0030123.g002
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6 mice depleted of NK cells by antibody treatment [43], we
observed accumulation of effector CD8 T cells in BALB/c
mice at later time points after challenge.
In order to investigate the effector potential of the MCMV-
speciﬁc CD8 T cells observed at day 4 post-infection in Klra8
mice, we measured different parameters associated with the
protective functions of antiviral CD8 T cells, namely their
proliferation, by monitoring the expression of the marker Ki-
67 (Figure 4A), their capacity to produce IFN-c in response to
antigen-speciﬁc restimulation in vitro using intracellular
staining (Figure 4B) and ELISPOT (Figure S3), and their
cytotoxic potential by measuring antigen-speciﬁc target cell
killing in vivo (Figure 4C). For each of these parameters, we
observed an accelerated acquisition of effector functions by
CD8 T cells from Klra8 mice when compared to BALB/c
animals.
As Klra8 and BALB/c mice differ for the whole NK cell
locus, which includes genes expressed in several leukocyte
subsets, we sought to ensure that the differences observed in
the activation kinetics of CD8 T cells between these two
mouse strains i) were not due to intrinsic differences in the
reactivity of CD8 T cells and ii) were dependent on Ly49H-
mediated NK cell activation. This was achieved by showing
that no accelerated expansion of CD8 T cells occurs in Klra8
animals i) when the antibacterial responses of Klra8 and
BALB/c mice are compared during Listeria monocytogenes
infection (Figure S4), or ii) in response to MCMV infection
when Klra8 mice are depleted of NK cells (Figure 5A), or
when the CD8 T cell responses of Klra8 and BALB/c mice are
compared during infection with a Dm157 virus as opposed to
infection with wild-type or revertant viruses (Figure 5B).
Moreover, the impact of efﬁcient NK cell activity on the
development of antiviral CD8 T cell responses was conﬁrmed
in mice of another genetic background, as a delay in antiviral
CD8 T cell activation was observed in B10.D2 animals
deﬁcient for Ly49H-mediated NK cell activation due to the
inactivation of the associated adaptor molecule DAP12
(B10.D2.DAP128), as compared to wild-type controls (Figure
5C). Altogether, these data show that efﬁcient NK cell
responses to a viral infection accelerate the development of
effector antiviral CD8 T cell responses.
The Ability of Efficient NK Cell Activity to Optimally
Promote Antiviral cDC and CD8 T Cell Responses Can Be
Overridden by Type I Interferons
To determine whether the dramatic reduction of pDC
IFN-a/b production by NK cell functions in Klra8 mice could
Figure 3. Kinetics of Antigen-Specific CD8 T Cells Expansion in Klra8 and
BALB/c Mice in Response to MCMV Infection
Splenic leukocytes were isolated from Klra8 and BALB/c mice on days 0,
4, 5, and 7 post–MCMV infection and analyzed for (A) total numbers of
CD8 T cells (TCRb
þ CD8a
þ), (B) CD43 expression on the total CD8 T cell
population, and (C) binding of IE-1-loaded MHC class I tetramers on the
total CD8 T cell population. CD43 expression on CD8 T cells and IE-1-
loaded MHC class I tetramer binding to CD8 T cells is shown for one
representative animal from groups of three mice for days 4, 5, and 7
post–MCMV infection. Numbers in dot plots represent percent CD43
hi or
percent IE-1 tetramer
þ CD8 T cells within the total CD8 T cell population.
Graphs represent the total numbers (in millions) of CD8 T cells, CD43
hi
CD8 T cells, or IE-1 tetramer
þ CD8 T cells. Results are expressed as mean
6 SD of three mice per group. One experiment representative of four for
(A–C) is shown. **p   0.01.
doi:10.1371/journal.ppat.0030123.g003
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NK Cells Shape Antiviral DC and CD8 T ResponsesFigure 4. Accelerated Acquisition of CD8 T Cell Effector Functions in Klra8 Mice in Response to MCMV Infection
Splenic leukocytes were isolated from Klra8 and BALB/c mice on days 0, 4, 5, and 7 post–MCMV infection.
(A) The CD8 T cell population was analyzed directly ex vivo for intracellular expression of Ki-67. Intracellular expression of Ki-67 is shown for one
representative animal from groups of three mice for days 4, 5, and 7 post–MCMV infection. Numbers in dot plots represent percent Ki-67
þ CD8 T cells
within the total CD8 T cell population. Graphs represent the total numbers (in millions) of Ki-67
þ CD8 T cells.
(B) The CD8 T cell populations were analyzed for their ability to produce IFN-c after antigen-specific re-stimulation with IE-1 peptide-pulsed P815.B7
cells. Intracellular expression of IFN-c is shown versus surface CD43 expression for the total CD8 T cell population for one representative animal from
groups of three mice. Numbers in dot plots represent percent IFN-c
þ CD8 T cells within the total CD8 T cell population. Graphs represent the total
numbers (in millions) of IFN-c
þ CD8 T cells.
(C) The CD8 T cell populations were analyzed for their ability to kill IE-1 and m164 peptide-pulsed target cells in vivo. Target cells were transferred into
mice at the time points indicated and the spleens harvested 4 h later. Histograms are gated on PKH26
þtarget cells. Numbers represent the percentage
of target cells killed for one representative animal from groups of three mice. Graphs represent the percentage of target cells killed.
Results in graphs are expressed as mean 6 SD of three mice per group for (A–C). One experiment representative of three for (A, B), and two for (C) are
shown. **p  0.01.
doi:10.1371/journal.ppat.0030123.g004
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NK Cells Shape Antiviral DC and CD8 T ResponsesFigure 5. Kinetics of Antigen-Specific CD8 T Cell Expansion in Response to MCMV Infection in Mice Lacking NK Cells or Ly49H-Mediated NK Cell
Activation
Splenic leukocytes were isolated at the time points indicated from (A) Klra8 mice and Klra8 mice depleted of NK cells infected with MCMV, (B) Klra8 and
BALB/c mice infected with in vitro–generated BAC-derived wild-type (WT), revertant (REV), or Dm157 viruses, and (C) B10.D2 and B10.D2-DAP128 mice
infected with MCMV. Total CD8 T cell numbers, CD43 expression on CD8 T cells, and IE-1-loaded MHC class I tetramer binding to CD8 T cells were
analyzed for (A–C). Graphs represent total numbers (in millions) of cells for each parameter as indicated. Results are expressed as mean 6 SD of two (A)
or three (B, C) mice per group. One experiment representative of two for (A–C) is shown. **p   0.01.
doi:10.1371/journal.ppat.0030123.g005
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NK Cells Shape Antiviral DC and CD8 T Responsesin part account for the ability of these mice to preserve an
intact cDC compartment and to mount early CD8 T cell
responses, we examined whether exogenous administration
of the cytokines in these animals could directly impact the
initiation of cDC and CD8 T cell responses despite efﬁcient
NK cell–mediated control of viral load. MCMV-infected
Klra8 mice were treated with recombinant mouse IFN-a as
described in Materials and Methods, and their DC or CD8 T
cell compartments were compared to those of control-
treated Klra8 and BALB/c mice (Figure 6A). The treatment
of Klra8 mice with IFN-a indeed led to a drastic reduction in
both CD11b and CD8a splenic cDCs, but not in pDCs, when
compared to their control-treated Klra8 counterparts. Like-
wise, IFN-a treatment induced a delay in the expansion of
total, CD43
hi, and IE-1 Tet
þ CD8 T cell numbers (Figure 6B).
Of note, the IFN-a treatment administered to the Klra8 mice
did not signiﬁcantly change the level of viral replication in
these animals. Very low but detectable levels of infectious
viral particles were observed in both control-treated and
IFN-a-injected Klra8 mice (1.9460.35 versus 1.9260.11 log
pfu/spleen), which contrasted sharply with the high viral
replication observed in BALB/c animals (5.260.04 log pfu/
spleen). These results demonstrate that exogenous injection
of IFN-a in Klra8 mice is sufﬁcient to decrease the numbers
of cDCs and to ablate early antiviral CD8 T cell responses,
and, therefore, that excessive levels of IFN-a can have a
direct negative impact on antiviral immune cell responses in
a manner that is independent of the level of viral replication
in the host. The possibility remains that other innate
cytokines, such as IL-12 and TNF-a, which are produced at
much higher levels in BALB/c as compared to Klra8 mice,
may also bear some contribution to this function, in a
synergistic or redundant manner with IFN-a/b. In any case,
our data strongly suggest that the ability of Klra8 mice to
preserve an intact cDC compartment and to mount early
CD8 T cell responses is in part due to their ability to control
viral replication very early without the need for the host to
produce high systemic levels of IFN-a/b. Altogether, our data
thus identify how naturally occurring differences in the
interactions between a virus and its host can tilt the balance
between the various functions of IFN-a/b, and eventually
other innate cytokines, towards conditions promoting the
induction of early adaptive immunity, rather than the
development of a state of transient immunosuppression.
Early Control of Viral Load by Drug Treatment in BALB/c
Mice Recapitulates the Effects of the NK Cell Activity of
Klra8 Animals on DC and CD8 T Cell Responses
We next aimed at further understanding the link between
NK cell functions, IFN-a/b production, and downstream
effects on DCs and CD8 T cells. As BALB/c mice have a much
higher viral burden after infection with MCMV, it seemed
plausible that the difference in viral load between Klra8 and
BALB/c mice could have an impact on the intensity of the DC
and CD8 T cell responses. In order to test the impact of the
extent of viral replication in vivo on pDC cytokine
production and on antiviral CD8 T cell activation, inde-
pendently of the function of NK cells, we sought a strategy to
control viral replication efﬁciently in BALB/c mice with a
tightly controlled timing and magnitude. To achieve this, we
utilized an MCMV (DN-SCP-MCMV) that is genetically
engineered so that its in vivo replication can be effectively
arrested by the administration of doxycycline [44].
Using this system, we were able to design a doxycycline
treatment protocol which, in BALB/c mice, closely mimics the
extent and the kinetics of efﬁcient NK cell–mediated control
of viral replication observed in Klra8. Indeed, under the
experimental conditions selected, the viral burdens in Klra8
mice and in DN-SCP-MCMV-infected, doxycycline-treated
BALB/c mice were comparable at the different time points
examined, and much lower than in untreated DN-SCP-
MCMV-infected BALB/c animals (Figure 7A). The reduction
in viral burden in doxycycline-treated DN-SCP-MCMV-
infected BALB/c animals led to a signiﬁcant, strong decrease
in the serum levels of the pDC-derived cytokines IFN-a and
IL-12p70 (Figure 7B) and allowed the maintenance of cDCs
(Figure 7C). Moreover, we observed an accelerated activation
Figure 6. IFN-a-Driven Loss of cDCs and Delay in CD8 T Cell Activation
(A) Splenic leukocytes were isolated on days 0 and 3 post–MCMV
infection from Klra8, Klra8 treated with IFN-a at 30 and 48 h post-
infection, and BALB/c mice. The total numbers (in millions) of pDCs,
CD11b cDCs, and CD8a cDCs were determined and are presented as in
Figure 2.
(B) Splenic leukocytes were isolated on days 0 and 4 post–MCMV
infection from Klra8, Klra8 treated with IFN-a at 30 and 48 h post-
infection, and BALB/c mice. Total numbers (in millions) of CD8 T cells,
CD43
hi CD8 T cells, and IE-1 tetramer
þ CD8 T cells were determined and
are presented as in Figure 3.
One experiment representative of two for (A, B) is shown. *p   0.05; **p
  0.01.
doi:10.1371/journal.ppat.0030123.g006
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to untreated, DN-SCP-MCMV-infected BALB/c mice. The
magnitude and kinetics of expansion of antiviral CD8 T cells
in doxycycline-treated DN-SCP-MCMV-infected BALB/c mice
was comparable to that which is observed in the presence of
the efﬁcient antiviral NK cell response of Klra8 mice (Figure
7D). The treatment of DN-SCP-MCMV-infected Klra8 mice
with doxycycline had no effect on any of the parameters
tested (unpublished data). Thus, our data indicate that, in
Klra8 mice, the ability of NK cells to dampen innate cytokine
production by pDCs and thus to promote optimal conditions
for the initiation of antiviral cDC and CD8 T cell responses
result from their exquisite capacity to control viral repli-
cation early and efﬁciently after infection.
Discussion
The results from this study demonstrate that efﬁcient NK
cell responses promote the accelerated generation of effector
antiviral CD8 T cells during infection in vivo, in part by
preventing the generation of very high, immunosuppressive
levels of antiviral cytokines. Thus, our study demonstrates
that NK cells can serve not only as effector lymphocytes but
also as a regulator of immune system function for defenses
against viral infections. Therefore, our data bring important
and original advances to the understanding of the contribu-
tions NK cells make to immunity against infectious disease, by
demonstrating that i) they control the functions of another
critical player in the innate antiviral responses, the pDC, and
modulate the cytokine milieu induced early after challenge,
Figure 7. Control of Early Viral Load Results in Decreased pDC Cytokine Production, the Maintenance of cDCs, and the Accelerated Expansion of
Antigen-Specific CD8 T Cells
(A) Spleens from Klra8, BALB/c, and BALB/c mice treated with doxycycline 20 h post-infection were harvested on days 0, 1.5, 2, and 3 post–DN-SCP-
MCMV infection and homogenized. Viral titers were determined and are presented as in Figure S1B.
(B) Serum from Klra8, BALB/c, and BALB/c mice treated with doxycycline 20 h post-infection was collected on days 0, 1.5, 2, and 3 post–DN-SCP-MCMV
infection. Cytokine levels of IFN-a and IL-12p70 were determined and are presented as in Figure 1.
(C) Splenic leukocytes were isolated from on days 0, 1.5, 2, and 3 post–DN-SCP-MCMV infection from Klra8, BALB/c, and BALB/c mice treated with
doxycycline 20 h post-infection. The total numbers (in millions) of pDCs, CD11b cDCs, and CD8a cDCs were determined and are presented as in
Figure 2.
(D) Splenic leukocytes were isolated on days 0, 4, and 5 post–DN-SCP-MCMV infection from Klra8, BALB/c, and BALB/c mice treated with doxycycline 20
h post-infection. Total numbers (in millions) of CD8 T cells, CD43
hi CD8 T cells, and IE-1 tetramer
þ CD8 T cells were determined and are presented as in
Figure 3.
One experiment representative of two for (A–C), and four for (D) are shown. *p   0.05; **p   0.01; § ¼ not detected.
doi:10.1371/journal.ppat.0030123.g007
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CD8 T cells. Other mechanisms through which NK cell
activities can modulate immune responses to pathogens have
been summarized in several recent reviews [8,45,46] and
include in vivo i) the regulation of the homeostasis and of the
maturation of DCs and ii) the prevention of a detrimental
persistence of the activation of the CD8 T cells at later time
points during the immune response. Very recently, it was also
shown that perforin-mediated NK cell killing down-modu-
lates the activation of macrophages and prevents the
development of a hemophagocytic lymphohistiocytosis-like
syndrome during MCMV infection [47].
Our results demonstrate that NK cells can dramatically
decrease the intensity and duration of pDC activation by
controlling viral burden, which prevents the production of
very high systemic levels of IFN-a/b, and eventually other
innate cytokines, that can have detrimental effects for the
host. We show that this mechanism also protects against the
MCMV-mediated loss of splenic cDCs [36]. It has been
reported that that both measles virus and LCMV can exploit
the host’s IFN-a/b response to inhibit cDC development and
drive cDC loss in vivo [19]. Our results suggest that MCMV
also can induce high production of IFN-a/b to promote its
own survival by ablating cDCs and delaying the activation of
antiviral effector CD8 T cells. In light of this observation, it is
interesting to note that MCMV has developed strategies to
actively counteract the antiviral responses to IFN-a/b or IFN-
c within infected cells [48], as opposed to the mechanisms
employed by negative-strand RNA viruses, which act to shut
down the production of these cytokines by infected cells [49]
or pDCs [50]. Indeed, even though complete deﬁciency in
IFN-a/b responses is associated with a dramatic increase in
the susceptibility of mice to MCMV infection [16], it clearly
appears that the beneﬁt of high level IFN-a/b production for
the host is less than that brought by an efﬁcient NK cell
response (since Klra8 mice show viral titers that are 1,000-
fold lower than those seen in BALB/c mice, even though Klra8
mice produce 100-fold less IFN-a/b). Thus, it is tempting to
speculate that the efﬁcient NK cell activity driven by the
Ly49H activating receptor and its ability to dampen pDC
IFN-a/b production and to promote adaptive immunity is a
direct host countermeasure to the subversion of the IFN-a/b
response by MCMV. Altogether, our results suggest that the
NK cell response governs the balance between the positive
and negative effects of IFN-a/b, and eventually other innate
cytokines, for the optimal orchestration of the immune
response to MCMV.
Our data indicate that efﬁcient NK cell activity contributes
to the adaptive arm of the immune response to MCMV by
promoting the accelerated expansion of antigen-speciﬁc CD8
Tc e l l s .L i k et h ec o n t r i b u t i o nN Kc e l l sm a k et ot h e
maintenance of the cDC compartment, our data support a
role for NK cell control of pDC IFN-a/b production for the
promotion of antigen-speciﬁc CD8 T cell expansion. IFN-a/b
can have both positive and negative effects on CD8 T cell
responses [20,21,51–53]. For example, the optimal expansion
of CD8 T cells in response to LCMV infection has been
demonstrated to be dependent on the ability of the CD8 T
cell compartment to receive IFN-a/b-mediated signals [53].
However, within the same viral system, IFN-a/b also drives the
early attrition of both antigen-speciﬁc and bystander CD8 T
cell populations [20,21]. Here, we show that the delay in the
expansion of antiviral effector CD8 T cells in the absence of
an efﬁcient NK cell response to MCMV occurs within the
context of excessive production of IFN-a/b by pDCs. More-
over, we demonstrate that exogenous administration of IFN-a
can override the ability of efﬁcient NK cell activity to
promote the accelerated expansion of functional antiviral
CD8 T cells. The IFN-a-mediated effects on CD8 T cell
expansion could be direct or a downstream consequence of
the loss of cDCs. However, our results suggest a direct activity
of IFN-a/b on CD8 T cells, as the administration of IFN-a
leads to the complete disappearance of early antiviral CD8 T
cells but only to an incomplete decrease in cDC numbers.
Although not the focus of this study, our data also show
that delayed CD8 T cell responses reach higher levels and are
sustained for longer periods of time in the absence of
efﬁcient antiviral NK cell activity, which is consistent with
previous observations [43]. This extended activation of the T
cell compartment is required for MCMV control under these
conditions and likely results from the poor ability of the
innate immune system to control the virus early. One could
hypothesize that this could also lead to chronic inﬂammation
and long-term detrimental effects for the host, including the
increased susceptibility of BALB/c mice to MCMV-induced T
cell–dependent autoimmune diseases such as myocarditis
[54]. Thus, efﬁcient NK cell responses could be beneﬁcial to
the host not only by early direct antiviral effects but also by
reducing the degree of antiviral T cell activation required for
later control of viral replication and therefore the indirect
costs this may bear for health.
To our knowledge, this study is the ﬁrst to demonstrate
how naturally occurring, genetically determined differences
in the interactions between a virus and its host can tilt the
balance between the various functions of IFN-a/b towards
conditions promoting the induction of early adaptive
immunity rather than towards the development of a state of
transient immunosuppression. Our data also conﬁrm that NK
cell antiviral functions prevent the generation of a chronic
state of CD8 T cell activation later during the infection that
may otherwise lead to immunopathology. A key question for
future studies will be to determine how general this function
of NK cells is for antiviral defense. Such mechanisms may also
be in place during HIV infection where genetic [55] or
functional [56–58] evidences suggest a role in the variation of
NK cell functions for resistance or susceptibility to the
development of AIDS, where detrimental effects of excessive
levels of IFN-a/b [59] or of pro-inﬂammatory cytokines [60,61]
have been recently suggested, and where the initiation of
antiviral CD8 T cell responses appears delayed [62–64]. This
could also be the case for infections with highly pathogenic
strains of inﬂuenza, as excessive production of pro-inﬂam-
matory cytokines have been shown to occur and proposed to
play a crucial role in immunopathology [65,66], while NK cells
can confer resistance through recognition of infected cells by
the NKp46 receptor [67]. Very recently, researchers have
demonstrated that human NK cells are able to recognize DCs
infected with the inﬂuenza or Ebola viruses [68,69], while a
correlation between unregulated IFN-a/b responses and a
malfunction of the switch from innate to adaptive immunity
has been reported during fatal SARS [70], which further
highlight the potential relevance of our observations to a
variety of viral infections. Thus, it will be important to
determine the impact of NK cell function on the modulation
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immunopathology in other models of viral infection. More-
over, our results imply that in individuals susceptible to such
viral infections, pharmacological control of viral replication
very early should beneﬁt them not only by directly limiting
viral cytopathogenicity, but also by establishing conditions
better suited to the development of balanced, protective
immunity, since this is the case in mice susceptible to MCMV
infection when viral replication is controlled by drug treat-
ment.
A role for NK cells in the generation of antitumor CD8 T
cell responses has been linked to their ability to increase
inﬂammation via secreting IFN-c and promoting IL-12
production by DCs [71,72]. Collectively, these studies and
ours reveal a role for NK cells as mediators of an ‘‘innate
cytokine balance’’ for the optimal generation of the immune
response, whereby NK cells are required to produce cytokines
to increase inﬂammation when it is intrinsically low (during
tumor development) and to prevent excessive production of
innate cytokines when it can be intrinsically high (in the
context of pathogenic encounters). Of note is the apparent
requirement, in both instances, for NK cells to engage in
cognate receptor–mediated interactions to naturally develop
immunoregulatory functions. For example, during the re-
sponse to MCMV, the systemic activation of NK cells by IL-12
to produce IFN-c in a Ly49H
  environment is not sufﬁcient
to promote their control of viral replication and their
associated immunoregulatory functions. These cognate in-
teractions could also enable NK cells to act as direct
regulators of antiviral immunity, as already illustrated for
the generation of antitumor CD8 T cell responses. During the
response to MCMV, Ly49H expression by NK cells dramat-
ically increases the efﬁciency of recognition and killing of
infected cells. Ly49H may also enable NK cells to deliver IFN-
c in a proper place and time to help the priming of antiviral
CD8 T cells in infected mice through a tripartite interaction
with MCMV-infected m157-expressing DCs. The importance
of these cognate interactions for the promotion of efﬁcient
NK cell functions may differ depending on the tissues and on
the target cell types, as exempliﬁed by the heightened
requirement for Ly49H-dependent mechanisms for MCMV
control in the lungs [73].
In conclusion, we demonstrate that efﬁcient NK cell
activity contributes to the optimal orchestration of innate
and adaptive immunity during the course of a viral infection
in vivo. The implications of these ﬁndings extend to the
design of therapeutic strategies to ﬁght human disease in two
ways, as they emphasize i) that the beneﬁts of innate cytokine
production for immune cell recruitment and activation can
be outweighed by detrimental effects that can directly reduce
the capacity of the host to ﬁght infection, as well as ii) the
need to better understand and take into account the complex
interactions of relatively rare cell types that occur in a
physiological context for the purpose of exploiting the
human immune system to promote health over disease.
Materials and Methods
Mice. BALB/c mice (Charles River Laboratories, http://www.criver.
com/) were purchased for use in these studies. C.B6-Klra8
Cmv1-r/UwaJ,
referred to as Klra8, (Jackson Laboratory, http://www.jax.org/),
B10.D2, and B10.D2-DAP12-deﬁcient (DAP128) animals were bred
in pathogen-free breeding facilities at the Centre d’Immunologie de
Marseille-Luminy (Marseille, France). Experiments were conducted in
accordance with institutional guidelines for animal care and use.
Protocols have been approved by the French Provence ethical
committee (number 04/2005) and the US Ofﬁce of Laboratory Animal
Welfare (assurance A5665–01).
In vivo treatment protocols. Stocks of wild-type Smith Strain
MCMV salivary gland extracts [14] and bacterial artiﬁcial chromo-
some (BAC)-derived wild-type, DN-SCP-MCMV [44], Dm157-MCMV,
and m157-revertant were prepared as previously described [73].
Infections were initiated on day 0 with the i.p. delivery of 5310
3 PFU
(for in vivo–derived virus) or 2310
5 PFU (for in vitro–derived virus).
These modest doses were chosen because they do not induce
lymphopenia in infected animals who harbor leukocyte numbers
equal to or greater than those of uninfected controls (not shown). In
addition, these doses are likely to be closer to the physiologic doses
reached upon natural exposure to the virus through contact with
infected animals. For the in vivo arrest of DN-SCP-MCMV repli-
cation, 200 lg of doxycycline was delivered by i.p. injection 20 h post-
infection followed immediately by the addition of 2 mg/ml
doxycycline plus 5% sucrose in the drinking water. 50,000 units of
recombinant mouse IFN-a (HyCult Biotech, http://www.hbt.nl/) was
administered by i.p. injection at 30 and 48 h post–MCMV infection.
This dose was titrated in ELISA and shown to correspond to 25 ng of
the ELISA IFN-a standard. Thus, since the cytokine titers measured
by ELISA in the serum of BALB/c mice at 36 h post-infection range
between 5 and 10 ng/ml, and the volume of the lymph and blood of an
adult mouse can roughly be estimated around 5 ml, the dose of
rmIFN-a injected in Klra8 mice should be similar to the physiologic
levels of the cytokine naturally induced in infected BALB/c mice. NK
cells were depleted by delivery of 100 lg of puriﬁed anti-NK1.1 mAb
(PK136) on days  1 pre–MCMV infection, and days 1 and 3 post–
MCMV infection. Control mice were treated with 100 lg of mouse
IgG (Jackson ImmunoResearch Laboratories, http://www.
jacksonimmuno.com/). Uninfected mice were depleted of NK cells
on the schedule of day 4 infected mice. To assess NK cell depletion, a
combination of anti-DX5 and anti-TCRb staining was used in order
to avoid the risk of underevaluating the numbers of remaining NK
cells, as may have occurred due to a potential problem of epitope
masking if the antibody used for immunophenotyping had been the
same as the one used for depletion. NK cell depletions were greater
than 98% (Figure S5).
Isolation of lymphocytes. For the analysis of CD8 T cell
populations, spleens were minced, passed through nylon mesh and
washed in PBS, 5 mM EDTA, and 3% FCS (PBS/EDTA/FCS). For the
analysis of DC populations, spleens were digested by collagenase
(liberase CI; Boehringer Mannheim, http://www.roche.com/) and
teased apart by repeating pipeting in PBS/EDTA/FCS. In both
protocols, erythrocytes were osmotically lysed by ammonium
chloride treatment. Thereafter, cell suspensions were kept in PBS/
EDTA/FCS unless speciﬁed otherwise. Total live splenocytes were
counted by trypan blue exclusion using a hemocytometer. Total
numbers of speciﬁc leukocyte subsets were calculated for each
individual mouse as (percent of these cells in the live gate of total
splenocytes) 3 (total live splenocyte numbers).
CD8 T cell stimulation for IFN-c production. For intracellular IFN-
c detection, splenic lymphocytes were isolated and then incubated
with IE-1 (
168YPHFMPTNL
176) or m164 peptide (
257AGPPRYSRI
265)
(10
 7 M) pulsed P815.B7 cells at a 10:1 ratio for 6 h with brefeldin A
(Sigma-Aldrich, http://www.sigmaaldrich.com/) added for the last 3 h
of culture. Cells were then harvested and analyzed for CD8a, CD43,
and intracellular IFN-c protein by three-color staining followed by
ﬂow cytometry.
In vivo cytotoxicity assay. Antigen-speciﬁc CD8 T cell–mediated
cytotoxicity was assayed as described in [74]. Brieﬂy, splenocytes from
naive mice were costained with PKH26 (Sigma-Aldrich) and either 1
lM, 100 nM, or 1 nM CFSE (Molecular Probes, http://probes.
invitrogen.com/). Labeled cells were then pulsed with the indicated
peptides, mixed in equal ratios, then transferred i.v. (5 3 10
6 total
cells) into the indicated groups of mice. Lymphocytes were isolated
from the spleens of recipient mice 4 h post-transfer and analyzed for
PKH26 (all transferred cells) and level of CFSE expression (unpulsed
or peptide-pulsed cells). Percent killing within the PKH26
þ gate was
calculated by: 100   ([(% peptide-pulsed in infected/% unpulsed in
infected)/(% peptide-pulsed in uninfected/% unpulsed in unin-
fected)] 3 100).
Quantiﬁcation of viral titers and serum cytokine levels. Spleens
were homogenized [14], and viral titers were determined by plaque
assay using mouse embryonic ﬁbroblasts with centrifugal enhance-
ment or NIH-3T3 cells [73]. Serum was collected at the indicated time
points and cytokine levels were determined by ELISA for IFN-a (PBL
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12p70 (R&D Systems, http://www.rndsystems.com/) per the manufac-
turer’s instructions.
Abs and reagents. DX5-PE, CD43-PE (clone 1B11), CD11c-PE
(clone HL3), CD8a-PerCp (clone 53–6.7), TCR-b-allophycocyanin
(clone H57–597), IFN-c-allophycocyanin (clone XMG1.2), IL-12-
allophycocyanin (clone C15.6), and streptavidin-PE were purchased
from BD Pharmingen (http://www.bdbiosciences.com/). CD8a-FITC
(clone CT-CD8a) was purchased from Caltag (http://www.caltag.com/).
Ki-67-FITC (clone MM1) was purchased from Novocastra (http://www.
vision-bio.com/). Puriﬁed rat anti-mouse IFN-a (clone F18 and
RMMA-1) and anti-IFN-b (clone RMMB-1) were purchased from
TEBU-Bio (http://www.tebu-bio.com/). 120G8 mAb was provided by
Schering-Plough (http://www.schering-plough.com/) and conjugated
to Alexa Fluor-488 using a kit from Molecular Probes. Isotype
controls for each mAb were purchased from the appropriate
manufacturer. The following tetramers conjugated to PE were
obtained through the NIH Tetramer Facility (Atlanta, Georgia,
United States): H-2L(d)/IE-1(
168YPHFMPTNL
176)a n dH - 2 D ( d ) /
m164(
257AGPPRYSRI
265). The above-mentioned reagents were used
for FACS analysis in this study.
Flow cytometric analysis. Cells were ﬁrst incubated with 2.4G2
mAb for 20 min. Cells were then stained with mAbs speciﬁc for cell
surface markers or isotype controls for 30 min at 4 8C. Cells were then
washed and ﬁxed in 2% paraformaldehyde in PBS. Intracellular
staining for Ki-67, IFN-c, and IL-12 was performed using the Cytoﬁx/
Cytoperm kit (BD Pharmingen). Intracellular staining for IFN-a/b was
performed as previously described [35]. Depending on the experi-
ments, 2.5 3 10
5 to 2 3 10
7 events were collected on a FACSCalibur.
The data were acquired and analyzed using CellQuest software (BD
Biosciences). Isotype controls were used to set gates for the presented
FACS analyses.
Statistical analyses. Statistical analyses were performed in Micro-
soft Excel 5.0 (Microsoft Corporation, http://www.microsoft.com/)
using Student’s two-tailed t tests. Mean 6 standard deviation (SD) was
calculated for each graph. If visually absent, error bars are too small
to be depicted based on the scale of the y-axis.
Supporting Information
Figure S1. Klra8 Mice but Not BALB/c Animals Show a Dramatic
Expansion of NK Cells during MCMV Infection and Control Early
Viral Replication Efﬁciently through NK Cell Activity
Found at doi:10.1371/journal.ppat.0030123.sg001 (437 KB TIF).
Figure S2. Impact of High Dose and Low Dose MCMV Infections, and
of NK Cell Depletion, on Systemic IFN-a/b Production in Klra8 Mice
Found at doi:10.1371/journal.ppat.0030123.sg002 (864 KB TIF).
Figure S3. Accelerated Acquisition of CD8 T Cell Effector Functions
in Klra8 Mice in Response to MCMV Infection
Found at doi:10.1371/journal.ppat.0030123.sg003 (502 KB TIF).
Figure S4. Kinetics of Antigen-Speciﬁc CD8 T Cell Expansion in
Klra8 and BALB/c Mice in Response to L. monocytogenes Infection
Found at doi:10.1371/journal.ppat.0030123.sg004 (385 KB TIF).
Figure S5. Assessment of the Efﬁciency of NK Cell Depletion
Found at doi:10.1371/journal.ppat.0030123.sg005 (223 KB TIF).
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